(2026). A Case of Adenocarcinoma of Unknown Primary Site in a Lynch Syndrome Patient Responds to Ipilimumab/Nivolumab. Case Reports in Gastrointestinal Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A Case of Adenocarcinoma of Unknown Primary Site in a Lynch Syndrome Patient Responds to Ipilimumab/Nivolumab."
Case Reports in Gastrointestinal Medicine 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A Case of Adenocarcinoma of Unknown Primary Site in a Lynch Syndrome Patient Responds to Ipilimumab/Nivolumab."
Case Reports in Gastrointestinal Medicine, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.